| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.023 | 0.9 |